<DOC>
	<DOC>NCT00447889</DOC>
	<brief_summary>This is a clinical study of gadoteric acid in non-coronary MR angiography.</brief_summary>
	<brief_title>A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Male or female, at least the age of legal maturity Strongly suspected of having noncoronary arterial disease, detected clinically Scheduled to undergo xray angiography examination Female patients must be using effective contraception or be surgically sterilized or postmenopausal. Females of childbearing potential must have a documented negative urine pregnancy test. Contraindication to magnetic resonance imaging (MRI) Any metallic medical device in the vascular territory for which the patient is to undergo imaging examinations Congenital morphologic vascular abnormalities Known allergy to gadolinium chelates Pregnant, breast feeding, or planning to become pregnant during the trial Received a gadolinium complex within 2 days or iron oxide nanoparticles within 7 days before the gadoteric acidenhanced magnetic resonance angiography (MRA) examination.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>